CTMX
Price
$3.81
Change
-$0.47 (-10.96%)
Updated
Dec 2, 04:59 PM (EDT)
Capitalization
726.88M
92 days until earnings call
Intraday BUY SELL Signals
NRSN
Price
$1.17
Change
-$0.00 (-0.00%)
Updated
Dec 2, 04:24 PM (EDT)
Capitalization
34.54M
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTMX vs NRSN

Header iconCTMX vs NRSN Comparison
Open Charts CTMX vs NRSNBanner chart's image
CytomX Therapeutics
Price$3.81
Change-$0.47 (-10.96%)
Volume$34.59K
Capitalization726.88M
NeuroSense Therapeutics
Price$1.17
Change-$0.00 (-0.00%)
Volume$400
Capitalization34.54M
CTMX vs NRSN Comparison Chart in %
CTMX
Daily Signal:
Gain/Loss:
NRSN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CTMX vs. NRSN commentary
Dec 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Hold and NRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 03, 2025
Stock price -- (CTMX: $4.29 vs. NRSN: $1.16)
Brand notoriety: CTMX and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 84% vs. NRSN: 56%
Market capitalization -- CTMX: $726.88M vs. NRSN: $34.54M
CTMX [@Biotechnology] is valued at $726.88M. NRSN’s [@Biotechnology] market capitalization is $34.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 2 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • CTMX’s FA Score: 2 green, 3 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, CTMX is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 4 TA indicator(s) are bullish while NRSN’s TA Score has 5 bullish TA indicator(s).

  • CTMX’s TA Score: 4 bullish, 4 bearish.
  • NRSN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CTMX and NRSN are a good buy in the short-term.

Price Growth

CTMX (@Biotechnology) experienced а +8.06% price change this week, while NRSN (@Biotechnology) price change was +9.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.65%. For the same industry, the average monthly price growth was -4.59%, and the average quarterly price growth was +53.79%.

Reported Earning Dates

CTMX is expected to report earnings on Mar 04, 2026.

NRSN is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (-1.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($727M) has a higher market cap than NRSN($34.5M). CTMX YTD gains are higher at: 316.505 vs. NRSN (-3.083). CTMX has higher annual earnings (EBITDA): 44.7M vs. NRSN (-8.55M). CTMX has more cash in the bank: 158M vs. NRSN (666K). NRSN has less debt than CTMX: NRSN (19K) vs CTMX (6.89M). CTMX has higher revenues than NRSN: CTMX (141M) vs NRSN (0).
CTMXNRSNCTMX / NRSN
Capitalization727M34.5M2,107%
EBITDA44.7M-8.55M-523%
Gain YTD316.505-3.083-10,265%
P/E Ratio14.30N/A-
Revenue141M0-
Total Cash158M666K23,724%
Total Debt6.89M19K36,237%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTMXNRSN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 26 days ago
88%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CTMX
Daily Signal:
Gain/Loss:
NRSN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OBSOX29.11N/A
N/A
Oberweis Small-Cap Opportunities
RYIIX171.39N/A
N/A
Rydex Internet Inv
GGGIX68.11N/A
N/A
Gabelli Global Growth I
AGGDX13.22N/A
N/A
American Century Focused Global Gr R6
NSBRX66.75-0.58
-0.86%
Nuveen Dividend Growth I

NRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRSN has been loosely correlated with NEVPF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NRSN jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
-2.27%
NEVPF - NRSN
49%
Loosely correlated
N/A
PBM - NRSN
38%
Loosely correlated
+4.89%
SLRX - NRSN
32%
Poorly correlated
-6.18%
CTMX - NRSN
31%
Poorly correlated
+0.23%
DNLI - NRSN
29%
Poorly correlated
-6.68%
More